2nd Circ. Backs Another Eli Lilly Win In Zyprexa MDL
The Second Circuit preserved another Eli Lilly & Co. win Monday in a suit in multidistrict litigation alleging it failed to warn about diabetes risks tied to its antipsychotic Zyprexa, finding...To view the full article, register now.
Already a subscriber? Click here to view full article